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osting by EAbstract Background: A large proportion of hospitalizations for diabetes are preventable. We
carried out this study to determine the prevalence and reasons for hospitalization in adults with dia-
betes in Kuwait.
Materials and methods: A cross-sectional study was conducted of all hospital admissions in the
Department of Medicine at Al-Sabah Hospital in Kuwait during a 2-month period. Admissions
were classiﬁed into three groups: (i) medical history of diabetes; (ii) unrecognized diabetes or
new hyperglycemia (i.e., an admission for fasting blood glucose P7 mmol/l or random blood
glucose P11.1 mmol/l); and (iii) no diabetes.
Results: Diabetes was the principal or secondary diagnosis in 40.6% of hospitalizations. Unrecog-
nized diabetes or new hyperglycemia was found in 12.9% of the patients. Patients with diabetes or
new hyperglycemia were signiﬁcantly older and had longer hospital stay compared to non-diabetic
patients. The three most common reasons for hospitalizations in patients with diabetes were dis-
eases of the cardiovascular system (53.6%), diseases of the respiratory system (22.8%), and diabetes
as a principal diagnosis (6.3%). The ﬁve most frequent speciﬁc causes for hospitalizations in
patients with medical history of diabetes as a secondary diagnosis were acute coronary syndrome
(27.2%), pneumonia (14.3%), heart failure (11.2%), cerebrovascular accident (10.3%), and chronic
obstructive airway disease (3.6%).O. Box 4078, Safat 13041,
5 2488 3418.
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A.M.S. Al-Adsani, K.A. Abdulla66Conclusion: Diabetes imposes a great burden on secondary health care in Kuwait. Effective pri-
mary care and hospital outpatient preventive and treatment strategies, including education, multi-
factorial intervention for cardiovascular risk factors, and inﬂuenza and pneumococcal
immunizations for patients with diabetes may reduce these hospitalizations among diabetic patients.
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Diabetes mellitus is a major public health problem, affecting
300 million people worldwide [1]. Diabetes is a costly condition
associated with signiﬁcant levels of morbidity and mortality. In
the United States, hospitalization attributable to diabetes costs
50% of the total direct medical expenditure for diabetes [2].
Morbidity is mainly due to associated complications, including
cardiovascular, cerebrovascular and peripheral vascular dis-
eases, nephropathy, infection, and lower-extremity amputa-
tions. Risk factors for hospitalizations in diabetic patients
include poor glycemic control, longer diabetes duration, and
coexisting morbidity [3]. A large proportion of hospitalizations
for diabetes are preventable. Improvements in the quality of
primary care for diabetes were reﬂected by a decrease in diabe-
tes-related preventable hospitalizations [4]. Factors that may
have contributed to the decline in diabetes-related preventable
hospitalizations include early detection of diabetes [5], annual
screening for complications [6,7], multifactorial intervention
using medications with approved indications [8], education
classes [9], and immunizations against the commonest respira-
tory infections [10].
Diabetes in Kuwait is a major public health problem. The
Eastern Mediterranean Approach for Non-communicable dis-
eases survey, conducted in 2006 by the Ministry of Health, in
conjunction with the World Health Organization for surveil-
lance of the non-communicable disease risk factors, estimated
the prevalence of diabetes to be at 12.4% in Kuwaiti nationals
aged 20–65 years, using fasting blood glucose [11]. Further,
diabetes is a major risk factor for acute myocardial infarction,
stroke and chronic renal failure [12–14]. Yet data on hospital-
izations related to diabetes are scant [15]. We carried out this
study to determine the prevalence and reasons for hospitaliza-
tion in adults with diabetes.
2. Materials and methods
A cross-sectional study was conducted for all hospital admis-
sions in the Department of Medicine at Al-Sabah Hospital
in Kuwait during a 2-month period (1st January–29th Febru-
ary 2008). The Department of Medicine at this hospital admits
only patients with clinical medical conditions; patients admit-
ted for surgical procedures were not included in this study.
Data were extracted manually from the medical records.
Admissions were classiﬁed into three groups: (i) medical his-
tory of diabetes; (ii) unrecognized diabetes or new hyperglyce-
mia (i.e., admission fasting blood glucose P7 mmol/l or
random blood glucose P11.1 mmol/l); and (iii) no diabetes.
Demographic data, smoking status, reason for admission, fast-
ing or random blood glucose, and duration of hospital stay
were recorded. The type of known diabetes was recorded, as
reported by the admitting physician. Data on the duration of
diabetes were not included because of lack of reporting byphysicians. Pre-existing history of hypertension, dyslipidemia,
coronary heart disease, or cerebrovascular disease was also re-
viewed. Patients were excluded from the study if their medical
record was not accessible (n= 28) or they did not have glucose
measured on admission (n= 1).
Data management and analysis were conducted using the
SPSS program. Continuous variables are presented as
means ± SD, whereas categorical variables are presented as
numbers and percentages. The v2 test was used to test for dif-
ferences in proportion between categorical variables while
analysis of variance (ANOVA) was used to compare between
means. A P value of <0.05 was considered to be statistically
signiﬁcant.
3. Results
Based on a review of the hospital medical records which ful-
ﬁlled the eligibility criteria (n= 552), diabetes was the princi-
pal or secondary diagnosis in 40.6% of hospitalizations.
Unrecognized diabetes or new hyperglycemia was found in
12.9% of the patients. Two patients who were admitted as
newly diagnosed with diabetes had diabetic ketoacidosis.
These two patients were not included in the statistical analysis
between the three groups.
3.1. Patients’ characteristics
The characteristics of the patients admitted during the study
period are summarized in Table 1. Hospitalized patients were
predominantly men. Among diabetic patients, the gender dif-
ference was less marked. Hospitalizations increased with old-
er age. Patients with diabetes or new hyperglycemia were
signiﬁcantly older, and had a longer hospital stay compared
to non-diabetic patients. A majority of patients with medical
history of diabetes had type 2 diabetes (97%) and were
60 years or older (63.4%). Among diabetic patients, Kuwaitis
constituted more than two thirds of hospitalized patients. A
pre-existing history of hypertension, dyslipidemia, bronchial
asthma, coronary and cerebrovascular diseases was more pre-
valent among diabetic patients. Diabetes medication in hospi-
talized patients with medical history of diabetes included
insulin (45.5%), oral agents (38.4%), oral/insulin (6.2%)
and diet (10.0%).
3.2. Reasons for admission
Table 2 summarizes the most common reasons and the speciﬁc
diagnosis of admission for hospitalized patients. The three
most common reasons for hospitalizations in patients with dia-
betes were diseases of the cardiovascular system (53.6%), dis-
eases of the respiratory system (22.8%), and diabetes as a
principal diagnosis (6.3%). The ﬁve most frequent speciﬁc
causes for hospitalizations in patients with medical history of
Table 2 Commonest reasons and speciﬁc diagnosis for hospitalizations for patients with medical history of diabetes.
Medical history of
diabetes (n= 224)
Unrecognized diabetes or new
hyperglycemia (n= 71)
No diabetes
(n= 255)
Category
Diseases of
cardiovascular system
120 (53.6) 27 (38.0) 96 (37.6)
Diseases of the
respiratory system
51 (22.8) 25 (35.2) 37 (14.5)
Diabetes as a principal
diagnosis
14 (6.3) NA NA
Speciﬁc diagnosis
Acute coronary artery
syndrome
61 (27.2) 16 (22.5) 35 (13.7)
Pneumonia 32 (14.3) 13 (18.3) 22 (8.6)
Heart failure 25 (11.2) 4 (5.6) 7 (2.7)
Cerebrovascular
accident
23 (10.3) 3 (4.2) 19 (7.5)
Chronic obstructive
airway disease
8 (3.6) 4 (5.6) 6 (2.4)
Data are number (%).
NA: not applicable.
Table 1 Characteristics of hospitalized patients.
Variable Total Medical history of diabetes Unrecognized diabetes or
new hyperglycemia
No diabetes P value
Gender
Male 372 (67.4) 133 (59.4) 53 (74.6) 184 (72.2) <0.01
Female 180 (32.6) 91 (40.6) 18 (25.4) 71 (27.8)
Age (years) 53.4 ± 17.8 62.7 ± 13.5 51.1 ± 17.1 46.2 ± 17.5 <0.0001
Age group (years)
<30 58 (10.5) 3 (1.3) 9 (12.7) 45 (17.6)
30–39 67 (12.1) 12 (5.4) 6 (8.5) 48 (18.8)
40–49 91 (16.5) 19 (8.5) 20 (28.2) 52 (20.4) <0.0001
50–59 113 (20.5) 48 (21.4) 12 (16.9) 53 (20.8)
+60 223 (40.4) 142 (63.4) 24 (33.8) 57 (22.4)
Nationality
Kuwaitis 300 (54.3) 160 (71.4) 28 (39.4) 110 (43.1)
Non-Kuwaiti Arabs 151 (27.4) 42 (18.8) 22 (31.0) 87 (34.1) <0.0001
South Asians 79 (14.3) 15 (6.7) 17 (23.9) 47 (18.4)
Others 22 (4.0) 7 (3.1) 4 (5.6) 11 (4.3)
Smoking statusa
Current smoker 135 (33.5) 45 (31.0) 17 (28.8) 73 (37.1)
Former smoker 63 (15.6) 22 (15.2) 15 (25.4) 25 (12.7) NS
Non-smoker 205 (50.9) 78 (53.8) 27 (45.8) 99 (50.3)
Hospital stay (days) 8.6 ± 10.0 10.1 ± 11.8 10.2 ± 11.6 6.8 ± 7.0 <0.001
Pre-existing history of:
Hypertension 286 (51.8) 183 (81.7) 22 (31.0) 80 (31.4) <0.001
Hyperlipidemia 187 (33.9) 141 (62.9) 10 (14.1) 36 (14.1) <0.001
Coronary heart disease 143 (25.9) 112 (50.0) 7 (9.9) 24 (9.4) <0.001
Cerebrovascular disease 60 (10.9) 43 (19.2) 5 (7.0) 12 (4.7) <0.001
Bronchial asthma 43 (7.8) 23 (10.3) 8 (11.3) 11 (4.3) <0.01
Data are means ± SD or number (%).
a Numbers do not add up to the total due to missing data.
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syndrome (27.2%), pneumonia (14.3%), heart failure
(11.2%), cerebrovascular accident (10.3%), and chronic
obstructive airway disease (3.6%).4. Discussion
The prevalence of diabetes in hospitalized adults was conserva-
tively estimated in the USA at 12.4–25%, and persons with
A.M.S. Al-Adsani, K.A. Abdulla68diabetes were hospitalized three times more frequently com-
pared with persons without diabetes [16]. In our study, we
found that the prevalence of known diabetes among hospital-
ized adult patients in Kuwait was 40.6%, suggesting that dia-
betic patients were hospitalized two to three times more
frequently than persons without history of diabetes. Consistent
with results of a study by Umpierrez et al., we found that
12.9% of hospitalized patients was admitted with unrecog-
nized or new hyperglycemia [17]. Supporting other reports
[18–20], we found that patients with diabetes or new hypergly-
cemia had longer hospital stay. The poor outcome observed in
hyperglycemia with or without diabetes may be attributed to
elevation of counter-regulatory hormones that accelerate
catabolism, hepatic gluconeogenesis and lipolysis, leading to
elevation of blood glucose, free fatty acids, lactate and other
mediators that further damage tissues and cause organ dys-
function, and immune dysfunction [18,21].
Consistent with other studies, cardiovascular and respira-
tory diseases were the main causes of hospitalization in
diabetic patients, accounting for more than 75% of hospital-
izations. Cardiovascular complications were the most frequent
cause of hospitalization among patients with diabetes and new
hyperglycemia [19]. Type 2 diabetes is associated with a mark-
edly increased risk of cardiovascular disease (CVD) morbidity
and mortality [22]. This has been attributed to hyperglycemia
per se and the high prevalence of CVD risk factors among pa-
tients with diabetes. The Diabetes Epidemiology Collaborative
Analysis of Diagnostic Criteria in Europe (DECODE) [23]
have shown that glucose is a continuous risk factor for
CVD, coronary artery disease, and stroke. Studies have indi-
cated that there is a substantial potential for the reduction of
CVD risk factors [24,25]. The Steno-2 study has shown that
intensive multifactorial interventions reduced the risk of car-
diovascular morbidity and mortality in patients with type 2
diabetes with microalbuminuria by about 50%, and this was
cost-effective [26–28].
The second most frequent reason for hospitalization among
our patients with diabetes and new hyperglycemia was the dis-
eases of the respiratory system, including pneumonia and
chronic obstructive airway disease. Diabetic patients are at in-
creased risk of pneumonia, chronic obstructive airway disease,
pulmonary ﬁbrosis and asthma [29]. Adult diabetic patients
were three times more likely to be hospitalized with pneumonia
than non-diabetic adults [3], with an increased risk of morbid-
ity and mortality [30–32]. Diabetic patients may have increased
susceptibility to pneumonia for several reasons, including
hyperglycemia, decreased immunity, impaired lung function
and chronic complications, such as renal failure, heart disease,
and pulmonary microangiopathy associated with diabetes [29].
Admission glucose levels of >11 mmol/l in type 2 diabetic
patients and of >6 mmol/l in non-diabetic patients was asso-
ciated with increased pneumonia-related morbidity and mor-
tality. For each 1-mmol/l increase, the risk of in-hospital
complications increased by 3–5% [33]. Inﬂuenza and pneumo-
coccal vaccination reduced hospital admissions in diabetic pa-
tients for any complications, including respiratory disease,
cardiovascular disease, and diabetic events by 54–79% and
mortality by 58% [34–37].
The third most frequent reason for hospitalization among
our diabetic patients was acute metabolic decompensation,
mainly diabetic ketoacidosis (DKA). A previous study on
young diabetics showed that non-adherence to insulin therapywas the most common identiﬁable cause of DKA [15]. DKA is
largely preventable through diabetes education programs
involving early detection, education and support, improved
follow-up care, and access to medical advice [38,39]. Further,
implementing a protocol for treating adult patients with
DKA decreases the length of stay in hospital [40].
Our study has at least three limitations. First is the use of a
manual medical record review, because of the lack of an elec-
tronic ﬁling system in our hospital, which has limited the study
period and thereby the number of ﬁles that can be recruited.
The second limitation is that the analysis of the duration of
diabetes and glycemic control was not included, because of
lack of data. Third, we studied only the patients who were hos-
pitalized in the Department of Medicine. Diabetic patients
admitted to the surgical department were not included in the
study, indicating that the burden of hospitalization due to dia-
betes might be overestimated in this study. The study done by
Umpierrez et al. [17] showed that the proportion of patients
admitted with known diabetes and with new hyperglycemia
was more in medical services compared to surgical services.
In conclusion, our data provide strong evidence that diabe-
tes imposes a great burden on secondary health care in Ku-
wait, accounting for about 41% of hospitalizations. Diseases
of the cardiovascular and respiratory system, and acute meta-
bolic decompensation were the commonest reason for hospi-
talizations. These results indicate that there is a potential to
improve health resource utilization and reduction of hospital-
ization by 50%. Furthermore, they emphasize the value of
effective health education programs, multifactorial interven-
tion for cardiovascular risk factors, and inﬂuenza and
pneumococcal immunizations for patients with diabetes, par-
ticularly for elderly subjects. Effective primary care and hospi-
tal outpatient preventive and treatment strategies may reduce
these hospitalizations and hospital stays among diabetic
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